scispace - formally typeset
R

Robert W. Egan

Researcher at Schering-Plough

Publications -  155
Citations -  11059

Robert W. Egan is an academic researcher from Schering-Plough. The author has contributed to research in topics: Interleukin 5 & Receptor. The author has an hindex of 54, co-authored 155 publications receiving 10790 citations.

Papers
More filters
Journal ArticleDOI

Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.

TL;DR: Electrophoretic mobility shift assays suggest that inhibition of NFκB activation may be an important mechanism for IL-10 supression of cytokine gene transcription in human monocytes.
Journal ArticleDOI

Phosphatidylcholine Hydrolysis by Phospholipase D Determines Phosphatidate and Diglyceride Levels in Chemotactic Peptide-stimulated Human Neutrophils: Involvement of phosphatidate phosphohydrolase in signal transduction

TL;DR: The results demonstrate that the fMLP-induced PLD utilizes diradyl-PC as the major substrate and alkyl-PA is degraded by a phosphohydrolase to produce alkyL-DG, which is derived almost exclusively from PC via the PLD/PA phosphohydrology pathway.
Journal ArticleDOI

The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases

TL;DR: The pharmacologic properties of vedolizumab, in conjunction with the gastrointestinal tropism of α4β7 integrin function, may ultimately confer an improved risk-to-benefit profile for patients with inflammatory bowel diseases.
Journal Article

IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells.

TL;DR: The present study provides the first evidence that, in human PBMCs, IL-10 inhibits cytokine synthesis by acting mainly at the level of cytokine gene transcription.